Bone Healing During Ninlaro Exposure
NCT04028115
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Ixazomib
Sponsor
Thomas Lund